The comparative meta-analysis revealed 109 up-regulated and 58 down-regulated genes (fold-change >1.5; adjusted p-value <0.1; 36 genes were more than 2-fold regulated) in ERG+ as compared to ERG− prostate cancer (Figure 2B, Table S1B). The gene discussed is ERG; the disease is Familial prostate cancer.